NEW YORK (GenomeWeb News) – Washington State's Life Sciences Discovery Fund has awarded approximately $3.7 million to fund regional research projects that aim to develop and use genomic and protein-based technologies for use in personalized diagnostics and therapeutics.

LSDF, funded by the Master Tobacco Settlement Agreement, said yesterday that it has awarded $2.4 million in funding under its Opportunity Grants program to support two large-scale research and development programs, and $1,250,000 to fund several proof-of-concept projects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.